基因预测的曼诺斯结合性莱克 (MBL) 水平和未来静脉血栓栓塞的风险 - 亨特研究
Christabel Esi Damoah1, Birgitte Tøndel1, Omri Snir2
1Thrombosis Research group (TREC), Department of Clinical Medicine, UiT - the Arctic University of Norway, Tromsø, Norway.
Journal of thrombosis and haemostasis : JTH
|February 15, 2026
概括
基因预测的曼诺结合性莱克 (MBL) 水平与年轻男性的静脉血栓栓塞 (VTE) 风险较高有关. 这种关联似乎受性别和年龄的影响,在老年男性或女性中没有发现显著的联系.
科学领域:
- 遗传学和血栓形成的原因
- 流行病学 流行病学
- 免疫学 免疫学 免疫学
背景情况:
- 血中曼诺结合性莱克 (MBL) 的升高是静脉血栓栓塞 (VTE) 的已知危险因素.
- MBL水平主要由遗传因素决定,还有一些环境影响.
- 了解对MBL水平的遗传贡献对于评估VTE风险至关重要.
研究的目的:
- 研究基因预测的MBL水平与发展VTE的风险之间的关联.
- 探索大规模基于人口的队列中这种关联的潜在性别和年龄差异.
主要方法:
- 利用了来自特伦德拉格健康研究 (HUNT) 的68999人的数据.
- 根据六种遗传变异,将个人分配到基因预测的低,中或高MBL类别.
- 采用考克斯回归来分析VTE风险 (危险比率) 跨MBL类别,按性别和年龄分层.
主要成果:
- 基因预测的MBL解释了50%以上的血MBL变异性.
- 在60-65岁以下的男性中,观察到高基因预测的MBL和增加的VTE风险之间的显著联系.
- 具体来说,年轻男性 (<50岁) 患有高MBL的风险增加了整体VTE,未引起的VTE和肺栓塞的风险.
- 在老年男性或女性中没有发现任何显著的关联.
结论:
- 基因预测的MBL和VTE风险之间存在温和的关联,主要在年轻到中年男性中.
- 性差异和环境因素与年龄的累积影响可能会掩盖老年人和女性的这种关联.
相关概念视频
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
355
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
355
01:30Venous Thrombosis I: Introduction
504
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
504
01:11Genome-wide Association Studies-GWAS
15.8K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.8K
01:29Venous Thrombosis III: Interprofessional Care
383
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
383
01:29Pharmacogenomics: Identification of New Drug Targets
9
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
9